We use cookies to ensure that we give you the best experience on our website.

Cookies Notice


A cookie is a small piece of text that allows a website to recognize your device and maintain a consistent, cohesive experience throughout multiple sessions. If you visit EDAN pages, both EDAN and third parties will use cookies to track and monitor some of your activities, and store and access some data about you, your browsing history, and your usage of the EDAN pages.


This policy describes how both EDAN and other third parties use cookies and how you can exercise a greater degree of control over cookies. Please keep in mind that this may alter your experience with our website, and may limit certain features.

General Browsing: We use cookies that are important for certain technical features of our website, like implementing fixes and improvements to our platform.

These cookies:

    - Enable behavior in our Products or Services that is tailored to the activity or preferences of a person visiting our properties

    - Allow users to opt out of certain types of modeling or personalization in our products

    - Collect information on our users’ preferences in order to create more useful products

    - Maintain the regular business operations of our Advertising and Marketing departments

    - Help to diagnose and correct downtime, bugs, and errors in our code to ensure that our products are operating efficiently

Analytics: We use cookies to compile usage activity in order to better cater our Products and Services offerings to you, and to third parties. We DO NOT share identifiable “raw” data with our clients or any third parties, however we do make high-level decisions based on aggregated data about your usage of our Products and Services.

These cookies:

    - Monitor site traffic and behavior flows of users

    - Measure the effectiveness of products

    - Measure the effectiveness of off-site marketing campaigns and tactics


In general, we collect most data from you via form submission. However, there are cases when visiting our site and/or using our platforms in which we may receive certain information through the use of cookies. This data will generally not include personally identifying information about you.

    - Unique identification tokens

    - User preferences such as favorite tags (for anonymous users only)

Third Party Cookies

The use of cookies, the names of cookies, and other cookies related cookies technology may change over time and EDAN will make all reasonable efforts to notify you by updating our cookies table where material changes occur and from time-to-time.


If you don’t want EDAN to use cookies when you visit EDAN home pages, you can opt-out of certain cookie related processing activities when you visit the pages. If you opt-out of cookies, we have to set a cookie to tell us that. Please note that EDAN may not work properly and you may have diminished functionality if you opt-out of certain cookies.If you decide that you do not want cookies to be set on your device by our third-party Partners, you can adjust the settings on your internet browser and choose from the available Cookies setting to best meet your preferences. While setting options may vary from browser to browser, you can generally choose to reject some or all cookies, or instead to receive a notification when a cookie is being placed on your device. For more information, please refer to the user help information for your browser of choice. Please keep in mind that cookies may be required for certain functionalities, and by blocking these cookies, you may limit your access to certain parts or features of our sites. You can manually delete the cookies at any time.

Company News Exhibitions & Events EMR

Edan Diagnostics to Acquire Molecular Diagnostic (POCT) Platform from LGC


San Diego, CA, October 28, 2019 -- Edan Diagnostics, Inc., a wholly own subsidiary of Edan Instruments, Inc., a world leader in the development and manufacture of bio-electronic devices and laboratory analyzers for medical diagnostics, and LGC, a global life science tools leader, announced today the sale of LGC’s ClariLight molecular diagnostics (Point of Care Testing) POCT platform to Edan.

The acquisition includes a partnership with LGC for the development of molecular diagnostic assays designed for Clarilight and the supply of enzymes and oligonucleotides required for manufacturing. The instrument and test cartridges will be developed, manufactured and marketed by Edan, and sold through its expanding global distribution network. The Company anticipates the launch of its initial products within 2 years.

Zhang Hao, Edan CEO, remarked, “We believe that this acquisition will jump-start our entry into the rapidly growing, molecular diagnostic market. There is a growing need for this type of testing throughout the world. The opportunity to continue to work with LGC provides additional confidence that we will be able to launch our first products in this area as planned.”

Brian Kim, LGC President remarked, “LGC is pleased to see the Clarilight platform will be commercialized by Edan. In addition, we are delighted to form an ongoing partnership to help Edan bring to market the molecular diagnostic assays that will run on Clarilight. I believe our ongoing partnership with Edan, a leading medical device company, will benefit both companies.” 



About LGC

LGC is an international leader in the extended life sciences sector, including human healthcare, agri-food & the environment. LGC provides a comprehensive range of reference materials, proficiency testing schemes, genomics reagents and instrumentation, as well as research and measurement services. Its scientific tools and solutions enable organizations to advance research, develop new products and form an essential part of their quality and compliance procedures.

LGC’s 2,800 employees include internationally-recognized scientists who are experts in their field. Headquartered in London, it operates out of 19 countries worldwide and is extensively accredited to quality standards such as GMP, GLP, ISO 13485, ISO 17034, ISO 17043, ISO/IEC 17025 and ISO 9001.

LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement. LGC has been privately-owned since 1996 and has diversified through internal investment and acquisition to be an international leader in its chosen niche markets. LGC is now owned by funds affiliated with KKR.

For more information, please visit www.lgcgroup.com

Media contact details


Julian Quigley

Media Relations & Social Media Manager

+44 (0)20 8943 8491



About EDAN Instruments, Inc.

Founded in 1995, EDAN has been continually striving to provide medical devices and solutions for customers. The faith of “Bringing Innovation and Value Together to Improve Human Condition” permeates every corner of EDAN’s corporate culture. With the commitment to becoming the pillar of the world healthcare industry and providing optimal services for the customers, EDAN has created a great momentum to become more internationalized and offer an innovation -oriented future.

EDAN provides more than 100 types of medical products, ranging from Obstetrics & Gynecology Products, Patient Monitoring Products and Diagnostic Cardiology Based Products, to Ultrasonic Imaging Systems and In-vitro Diagnostic Products, building solid foundations for future product exploration, as well as providing innovative products and excellent services to customers in over 160 countries and regions worldwide.

Headquartered in Shenzhen, China, EDAN operates 20 subsidiaries and 5 R&D centers around the world. Domestically, EDAN has reached up to 30,000 medical facilities with Industry Leading Healthcare solutions. Catering to the needs of Healthcare professionals and their patients, EDAN is and will Always be on the way of dedicating in innovation of products and services.

For more information, please visit www.edan.com

Contact Details


Sison Liu

Securities Affairs Representative